Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AVANOS MEDICAL, INC. | Chief Executive Officer | Common Stock | 242K | $3.47M | $14.33 | Apr 14, 2025 | Direct |
Orchestra BioMed Holdings, Inc. | Director | Common Stock, par value $0.0001 per share ("Common Stock") | 45K | $119K | $2.65 | Aug 7, 2025 | Direct |
Orchestra BioMed Holdings, Inc. | Director | Stock Option (Right to Buy) | 36.8K | Jun 24, 2025 | Direct | ||
Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | Apr 4, 2023 | Direct | |
Apollo Endosurgery, Inc. | Director | Stock Option (Right to Buy) | 0 | $8.69 | Apr 4, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OBIO | Orchestra BioMed Holdings, Inc. | Aug 7, 2025 | 1 | $0 | 4 | Aug 8, 2025 | Director |
OBIO | Orchestra BioMed Holdings, Inc. | Jun 24, 2025 | 2 | $0 | 4 | Jun 26, 2025 | Director |
AVNS | AVANOS MEDICAL, INC. | Apr 14, 2025 | 0 | $0 | 3/A | Apr 24, 2025 | Chief Executive Officer |
OBIO | Orchestra BioMed Holdings, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
OBIO | Orchestra BioMed Holdings, Inc. | Mar 26, 2024 | 2 | $0 | 4 | Mar 28, 2024 | Director |
OBIO | Orchestra BioMed Holdings, Inc. | Mar 26, 2024 | 0 | $0 | 3 | Mar 28, 2024 | Director |
APEN | Apollo Endosurgery, Inc. | Apr 4, 2023 | 6 | $0 | 4 | Apr 4, 2023 | Director |
APEN | Apollo Endosurgery, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
APEN | Apollo Endosurgery, Inc. | Jun 17, 2021 | 2 | $46.7K | 4 | Jun 21, 2021 | Director |
APEN | Apollo Endosurgery, Inc. | May 19, 2021 | 16 | -$129K | 4/A | May 20, 2021 | Director |